KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) FCF Margin (2017 - 2026)

Cardlytics filings provide 10 years of FCF Margin readings, the most recent being 16.52% for Q1 2026.

  • Quarterly FCF Margin fell 443.0% to 16.52% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 2.36% through Mar 2026, up 330.0% year-over-year, with the annual reading at 2.58% for FY2025, 697.0% up from the prior year.
  • FCF Margin hit 16.52% in Q1 2026 for Cardlytics, down from 3.83% in the prior quarter.
  • Across five years, FCF Margin topped out at 10.68% in Q2 2023 and bottomed at 32.39% in Q1 2022.
  • Average FCF Margin over 5 years is 8.59%, with a median of 6.18% recorded in 2022.
  • The largest annual shift saw FCF Margin skyrocketed 2561bps in 2023 before it plummeted -2054bps in 2024.
  • Cardlytics' FCF Margin stood at 6.18% in 2022, then skyrocketed by 141bps to 2.54% in 2023, then crashed by -808bps to 18.0% in 2024, then soared by 79bps to 3.83% in 2025, then tumbled by -331bps to 16.52% in 2026.
  • Per Business Quant, the three most recent readings for CDLX's FCF Margin are 16.52% (Q1 2026), 3.83% (Q4 2025), and 3.96% (Q3 2025).